Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis.
about
GTP cyclohydrolase 1 inhibition attenuates vasodilation and increases blood pressure in ratsThe ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping studyTetrahydrobiopterin in cardiovascular health and disease.Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 miceRole of marginal vitamin C deficiency in atherogenesis: in vivo models and clinical studies.Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasmDyslipidaemia in rheumatological autoimmune diseasesThe pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.Endothelial dysfunction and cardiovascular disease.Modeling of biopterin-dependent pathways of eNOS for nitric oxide and superoxide production.Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats.NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunctionNovel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterinThe two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis.eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity.Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension.Recent advances in understanding endothelial dysfunction in atherosclerosis.The Human Microcirculation: Regulation of Flow and BeyondMechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertensionSickle cell disease: role of reactive oxygen and nitrogen metabolites.Endothelial nitric oxide (NO) and its pathophysiologic regulationGuanosine triphosphate cyclohydrolase I expression and enzymatic activity are present in caveolae of endothelial cells.Selective up-regulation of arginase-1 in coronary arteries of diabetic patients.Estradiol increases guanosine 5'-triphosphate cyclohydrolase expression via the nitric oxide-mediated activation of cyclic adenosine 5'-monophosphate response element binding protein.Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function.Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.Oxidative stress and early atherosclerosis: novel antioxidant treatment.Targeting vascular (endothelial) dysfunction.Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis.Production of sepiapterin in Escherichia coli by coexpression of cyanobacterial GTP cyclohydrolase I and human 6-pyruvoyltetrahydropterin synthase.Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failureEndothelial function and early atherosclerotic changes.Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin.Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice.HPLC analysis of tetrahydrobiopterin and its pteridine derivatives using sequential electrochemical and fluorimetric detection: application to tetrahydrobiopterin autoxidation and chemical oxidation.Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease.Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?Tetrahydrobiopterin, a cofactor for NOS, improves endothelial dysfunction during chronic alcohol consumption.Impairment of neuronal nitric oxide synthase-dependent dilation of cerebral arterioles during chronic alcohol consumption.
P2860
Q28570674-F758E6DB-89A5-441B-86A6-F43BE45C7515Q28609860-B667A644-CE48-48F8-AB23-14F19780F44CQ33687812-B78CE188-136B-4DFB-920C-2CED54B03BFFQ34668310-DE739E8D-C042-48F2-8981-3CC9D04C75CBQ34984437-09A5E5DF-7B5A-41D3-9456-79C2BCE6D40BQ35022284-D9FF5E93-EFC9-4A74-9880-EE9E2705862CQ35029916-DC3AB4B2-5C5F-4F20-96CE-59A661D93473Q35055194-C6016123-0E64-4098-A447-F01A75604885Q35156621-6CF9BCE7-7343-4EF0-AFE0-96938595800AQ35252245-48CB6639-56FC-48AF-A9D3-7EB47B40BC77Q35642646-B530EC56-935B-44C8-BFFD-0A9567C4B09CQ35738597-7C48C942-BC2A-405A-A3DF-B61BFE58AAF4Q35848552-70B6227B-34C3-45A0-A0FE-B8F34CDBDC1BQ35888589-69DFB9CC-E99C-4B4C-A754-DA9842D100BDQ35889758-7827D404-2186-4B92-B9D5-6EF8002E3BB4Q36042654-D6D8DDF4-B9D8-43CB-9015-D8B594249459Q36440894-4070CD12-74AA-475C-ADF4-FF860AEA71CDQ36547176-6E82B76C-E83A-42E0-A7EF-C82A8A0C5F47Q36753476-DF7BDF96-BE07-4F5D-ADFB-72F0544AF31DQ36889232-FE4A12AA-5EFE-4885-AC23-58983CE4F300Q36992714-CE4889DF-705C-4C72-9BCA-3094B89C11E9Q37107580-5CC6C070-2CA4-4856-ADD5-74A3043681E2Q37199274-B1EED170-C2D1-4821-90E5-AFC205F8D11CQ37281168-9A5F1F5A-F5F5-4D8D-BD88-8288583218AEQ37306295-CC5D42BD-6B74-4D52-9CBF-81990F67B608Q37309441-11737978-FFEC-44BE-A83C-E5E5257DC55AQ37968218-65346733-571E-4F79-907D-BAE90EBC7EF9Q38269619-3425C1EE-D7DB-4C3A-883D-9E482655B993Q38836199-1F9C6192-2C56-4DD7-AA63-09E7D2C367C9Q39038155-D6A96B0F-1758-4C6D-B568-68763B1B802FQ39639799-6A8E8055-C52F-4DD8-8C9F-B0B8C1D9BE01Q40374460-36C96F2A-E85A-40E7-9441-5C9268820CBCQ40409861-50A37FDD-284C-4D84-9E0F-23AA58FB95B0Q40485897-DECE0341-6D90-4309-BE4B-C4AB9646AC11Q41966707-9C399E05-5781-414E-9994-E84F8B3C9F88Q42576287-5D1CE4E0-9343-4D8F-8CC7-5B99F997EF3EQ42976475-353ED26F-EFA8-40CA-9D15-A642EEE10003Q43610482-A730EFB7-D90D-4194-B037-3A0ADA3237F6Q43773099-15AA76A9-0433-4AED-A7AE-3B21EF2E2626Q44015269-61ABE583-F08A-4838-BBD8-9AF47FB2CF15
P2860
Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Endothelial dysfunction of cor ...... obiopterin in atherosclerosis.
@ast
Endothelial dysfunction of cor ...... obiopterin in atherosclerosis.
@en
type
label
Endothelial dysfunction of cor ...... obiopterin in atherosclerosis.
@ast
Endothelial dysfunction of cor ...... obiopterin in atherosclerosis.
@en
prefLabel
Endothelial dysfunction of cor ...... obiopterin in atherosclerosis.
@ast
Endothelial dysfunction of cor ...... obiopterin in atherosclerosis.
@en
P2093
P1433
P1476
Endothelial dysfunction of cor ...... obiopterin in atherosclerosis.
@en
P2093
P304
P356
10.1161/01.CIR.102.18.2172
P407
P577
2000-10-01T00:00:00Z